NEW PUBLICATION: Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder

NEW PUBLICATION: Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder

Investors & News

Our Partners

Scioto Biosciences was founded in 2017 as a partnership between Monon Bioventures and The Research Institute at Nationwide Children’s Hospital. Together, we are working to advance the rapidly-growing microbiome field by introducing innovative treatment delivery mechanisms.

Become a Partner

NEC Society does not endorse any product or company, and does not create, sponsor, or authorize the content of any communications, surveys, programs, or incentives from any company. NEC Society is a registered word mark of its owner and its use does not imply any affiliation, endorsement, or sponsorship by them.

Revolutionizing Therapeutic Interventions

The ABT Platform will help the industry realize the full potential of developing healthy bacteria as therapeutics.

Learn More